Sign in

CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475461709
Phone
(858) 684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award President & CEO acquired 280,000 shares (grant or award)
  7. 4 Grant or award COO/CFO acquired 115,750 shares (grant or award)
  8. 4 Grant or award Chief Commercial Officer acquired 93,750 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 93,750 shares (grant or award)
  10. 4 Grant or award EVP, Regulatory Affairs acquired 84,500 shares (grant or award)
  11. 4 Grant or award EVP, Tech Ops and Admin acquired 84,500 shares (grant or award)
  12. 4 Grant or award Chief Commercial Officer acquired 162,500 shares (grant or award)
  13. 4 Grant or award EVP, Tech Ops and Admin acquired 125,000 shares (grant or award)
  14. 4 Grant or award COO/CFO acquired 181,250 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 162,500 shares (grant or award)
  16. 4 Grant or award President & CEO acquired 437,500 shares (grant or award)
  17. 4 Grant or award EVP, Regulatory Affairs acquired 125,000 shares (grant or award)
  18. 4 Open-market buy Director bought 26,050 shares at $1.92 ($50,016)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 12 · 228 filings